{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang X"],"funding":["National Nature Science Foundation of China"],"pagination":["104"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9482291"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(1)"],"pubmed_abstract":["<h4>Background</h4>Ovarian malignant mesoderm mixed tumor (OMMMT) is a rare clinical entity. To provide reference for the treatment and prognosis of OMMMT, we analyzed the clinical features, pathology and molecular biology characteristic of published cases.<h4>Methods</h4>The English and Chinese reported cases of OMMMT were selected from PubMed, Clinical Trials.gov and CNKI database from 2000 to December 15th, 2021 following the PRISMA guidelines.<h4>Results</h4>A total of 63 literatures including 199 OMMMT cases were included. The average age of patients at diagnosis was 56.46 years, the highest incidence age was 60-65 years, and 82% of them were menopausal women. Most patients were diagnosed in FIGO III stage (59.64%). The most common symptom of OMMMT was abdominal pain (60.5%). 61.6% of"],"journal":["Journal of ovarian research"],"pubmed_title":["The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review."],"pmcid":["PMC9482291"],"funding_grant_id":["81903948, 81873330"],"pubmed_authors":["Wang S","Yao S","Shi W","Wang X","Ma K"],"additional_accession":[]},"is_claimable":false,"name":"The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review.","description":"<h4>Background</h4>Ovarian malignant mesoderm mixed tumor (OMMMT) is a rare clinical entity. To provide reference for the treatment and prognosis of OMMMT, we analyzed the clinical features, pathology and molecular biology characteristic of published cases.<h4>Methods</h4>The English and Chinese reported cases of OMMMT were selected from PubMed, Clinical Trials.gov and CNKI database from 2000 to December 15th, 2021 following the PRISMA guidelines.<h4>Results</h4>A total of 63 literatures including 199 OMMMT cases were included. The average age of patients at diagnosis was 56.46 years, the highest incidence age was 60-65 years, and 82% of them were menopausal women. Most patients were diagnosed in FIGO III stage (59.64%). The most common symptom of OMMMT was abdominal pain (60.5%). 61.6% of","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-06-01T02:30:50.383Z","creation":"2024-11-15T06:56:41.928Z"},"accession":"S-EPMC9482291","cross_references":{"pubmed":["36114551"],"doi":["10.1186/s13048-022-01037-6"]}}